Globus Medical (GMED) Reports In-Line Q2 EPS

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $133.6 million versus the consensus estimate of $126.89 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• JPMorgan Upgrades Wolters Kluwer NV (WKL:NA) (WTKWY) to Overweight
• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance